Walgreens kept doctor’s prescription data from store pharmacists, manager testifies over opioid Bellwether

(Photo credit: JHVEPhoto/Shutterstock)

Overview of the Walgreens MDL Opioid Epidemic:

  • Who: A judge overseeing a flagship opioid trial surrounding claims against Walgreens has heard recorded testimony from Eric Stahmann, a director of the company.
  • Why: Stahmann reportedly told the judge that Walgreens instructed its corporate and field management teams not to share doctors’ prescribing habits with store pharmacists.
  • Or: The landmark lawsuit concerns the opioid epidemic in San Francisco.

A judge overseeing a landmark lawsuit surrounding allegations that Walgreens and others helped fuel an opioid epidemic in San Francisco has heard testimony that the pharmacy chain was tracking but not sharing doctors’ prescribing habits.

Walgreens reportedly did not make prescription habits, which it kept in a database, available to its stores because it feared it would “cloud the judgment” of pharmacists filling prescriptions, Law360 reports.

A corporate director of Walgreens’ “pharmaceutical integrity team,” who said the data recorded by the company only relates to prescriptions filled in their separate locations, gave the recorded testimony.

The Walgreens Pharmacy Integrity Team was created in 2013 as part of an agreement with the United States Drug Enforcement Agency (DEA) that was entered into to resolve claims of violations involving record keeping and distribution, reports Law360.

Walgreens admits to refusing doctors’ prescribing habits

Walgreens chief executive Eric Stahmann reportedly said yes when asked if the company had instructed its corporate and field leadership teams not to release statistics on prescribing habits. from doctors to pharmacists.

Information contained in Walgreens’ corporate database but hidden from store pharmacists included the number of prescriptions filled at a store by a specific subscriber, the percentage of prescriptions containing a controlled substance from a subscriber, and a ranking. specific subscribers for particular drugs, Law360 reports.

Stahmann reportedly said the concern was that if a pharmacist receives too much information about a subscriber, it could be misinterpreted and/or make the pharmacist unnecessarily uncomfortable filling out the subscription.

Walgreens, Stahmann reportedly said, uses a “good faith dispensing policy,” which allows a pharmacist to contact a physician if they feel the need to verify the reasons for the prescription before filling it, Law360 reports.

“Our directive to pharmacists was to make a decision based on this particular prescription and not based on history or prescription data or anything else,” Law360 said Stahmann. “They were supposed to look at each individual prescription on a case-by-case basis.”

Last month, CVS Health agreed to pay $484 million to resolve claims related to its sale of prescription opioids in its Florida pharmacies.

In March, meanwhile, Johnson & Johnson reached a $26 billion settlement agreement to end allegations that it helped fuel an opioid epidemic in the United States.

Have you been affected by the opioid crisis? Let us know in the comments!

San Francisco is represented by its city attorney’s office, Lieff Cabraser Heimann & Bernstein LLP, Robbins Geller Rudman & Dowd LLP, Andrus Anderson LLP, Weitz & Luxenberg PC, Simmons Hanly Conroy LLC, and Levin Papantonio Rafferty.

the San Francisco Opioid Epidemic Lawsuit is City and County of San Francisco, et al., c. Purdue Pharma LP, et al.Case No. 4:21-cv-06770, in the U.S. District Court for the Northern District of California.

the Walgreens MDL Opioid Epidemic is In re: National Prescription Opioid LitigationCase No. 1:17-md-02804, in the U.S. District Court for the Northern District of Ohio.



Learn more about class actions and class action settlements:

We tell you about the money you can claim EVERY WEEK! Subscribe to our free newsletter.

Please note: Top Class Actions is not a settlement administrator or law firm. Top Class Actions is a source of legal information that reports on class action lawsuits, class action settlements, drug-related injury lawsuits, and product liability lawsuits. Top Class Actions does not handle claims and we cannot advise you on the status of a class action settlement claim. You should contact the Settlement Administrator or your attorney for any updates regarding the status of your claim, the Claim Form, or questions about when payments should be mailed.




Similar Items

Source link

About Alex S. Crone

Check Also

Top 20 most expensive prescription drugs in 2022

If you thought inflation was high, wait until you hear about rising specialty drug prices. …